A Study to Assess the Safety and Pharmacokinetics of AD-104-A

Inclusion Criteria: For all subjects * Adults aged 19 years and older * Body mass index(BMI) of 18 to 30 kg/m2 * Voluntarily given written informed consent For renal Impairment subjects * 30 ≤ eGFR \< 90 mL/min/1.73m\^2 For healthy subjects * eGFR ≥ 90 mL/min/1.73m\^2 Exclusion Criteria: * Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration * Other exclusions applied